This is the authors' abstract. We don't add key points for this paper.
This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA), drug approvals by year and by therapeutic category, and trends in the use of the FDA's various programs for expedited approval.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Darrow et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: